Mitsu Chem Plast Ltd Q4 FY2023 Concall Summary

Key Takeaways

• Demand rebounded sharply in Q4: After calling FY23 the weakest year in five, management reported robust Q4 demand that it expects to continue into Q1 FY24, with the pharmaceutical segment also beginning to recover.
• Realization hit a record ~₹190/kg: The jump was driven by both product mix improvement and higher raw material prices, with new products also contributing.
• New pails business is live and margin-accretive: A new machine added ~1,600 tons of capacity, the product is already shipping to lube customers, and management is targeting 60% utilization with 14–18% EBITDA margins in FY24.
• Hospital furniture commands a claimed 60%+ domestic market share: Demand is strong as healthcare infrastructure expands, and the company is now targeting exports after a year of international exhibitions.
• What to watch next quarter: Whether the Q4 demand strength actually carries into Q1 FY24, the pace of pails customer additions and utilization ramp, and any concrete announcement on the long-pending FPO or capacity expansion plans.

Demand Environment & Volume Recovery

• FY23 was an intentional low-water mark: Management described FY23 as the lowest-volume year of the last five and explicitly does not want investors to benchmark against it, framing the year as a trough from which growth has now resumed.
• Q4 exit rate was strong: Demand was described as very robust in the March quarter, and management believes the pickup will continue into Q1 FY24.
• Pharma is turning: The pharmaceutical segment was weak for the whole of last year but is now picking up, and the company is actively targeting it for FY24.
• No export cushion yet: The company has zero direct exports in its packaging business because drums and articles are difficult to ship economically, so the recovery is entirely domestic-led.
• Volume headroom exists: With current installed capacity and no new machines, management estimates the business can reach a topline of approximately ₹425 crore, implying significant volume runway before another expansion cycle is needed.

Dedhia: "Considering '22, '23 is a special year as we consider because that was a, last five years was a very low down, in last five years, '22, '23 was a very lowest one. So we don't want to benchmark '22, '23, but yes, we are on a growth path and definitely we look for a better growth."

New Product: Plastic Pails

• The pails business is now operational: A new machine was added in FY23, adding approximately 1,600 tons of capacity, and the product has already been kickstarted with positive customer response.
• Current focus is the lube industry: Management is concentrating initial sales efforts on lubricant customers; the paint industry is described as upcoming but no orders have been finalized with paint companies yet.
• Margins are attractive and have room to rise: Current EBITDA margins for pails are 14–18%, and management expects them to increase further as the product rolls out and utilization scales.
• Utilization target is 60% for FY24: The company is planning to utilize a minimum of 60% of pails capacity for the full year, with many customers already added and more being onboarded to improve profitability and sales.
• Customer base is building: 40+ new clients were added in the last quarter alone, and the pails segment is a meaningful contributor to that customer acquisition.

Hospital Furniture: Dominance & Export Ambition

• Claimed market share exceeds 60%: Management stated it holds 60%-plus market share in India for hospital furniture and suggested the true figure may be higher, though it declined to quantify the total addressable market or the organized/unorganized split when pressed by an analyst.
• Domestic demand is strong and structural: Infrastructure facilities are coming up at scale in India, and orders are flowing, driven by healthcare capacity expansion.
• Exports are the next leg: The company participated in multiple international exhibitions over the last year for hospital furniture, received good response and inquiries, and expects very good export results very soon.
• Revenue share dipped on mix, not weakness: The percentage contribution of hospital furniture to total revenue came down slightly in FY23, but only because the containers and other packaging businesses grew faster, not because furniture demand fell.

Dedhia: "I can say 60%-plus market share we have in India... Maybe more than that, but we just wanted to restrict the numbers by 60%."

Raw Material, Pricing & Margins

• Raw material prices have stabilized: Crude oil, a key input for HDPE, has not been too volatile over the last three to four months, and management is optimistic this favorable trend continues into FY24.
• Price pass-through is monthly and increasingly accepted: Price changes to customers happen on the first of every month to reflect weekly raw material movements; customers are increasingly agreeing to price hikes if they want quality, though competition remains cut-throat.
• Realization hit a record: FY23 sales per kg reached approximately ₹190, driven by both product mix change and higher raw material prices, with new products also contributing.
• EBITDA margin target is ~13%: Management is targeting not less than double-digit margins and is working heavily toward approximately 13%, with capacity utilization and raw material management as the primary cost optimization levers.
• Cost outlook is deliberately unforecasted: When asked how long cost headwinds might persist, management declined to predict, calling the market too dynamic.

Dedhia: "Our target is not definitely in a more than double digit only. So I think our target should be not less than 12% or 13%. But we are targeting very, very heavily for that. So around 13% is our target right now."

Balance Sheet & Capital Actions

• Working capital is healthy: The company maintained an 84-day working capital cycle and generated positive cash flow from operations of ₹21.99 crores, aided by focused efforts to reduce inventory and optimize receivables and payables.
• Term loans are largely retired: Many term loans have already been paid off; the remaining debt is primarily cash-credit working capital facilities.
• The FPO is still alive but uncommitted: Management noted that the market appears to have come back and said it will try to figure out the FPO in the coming months and announce very soon, describing it as one plan for debt reduction. If the FPO does not happen, the company will plan something different.
• Capacity expansion plans are under consideration: The company is in expansion mode and will announce plans once finalized and board-approved, described as coming very soon.
• Automotive components remain pre-revenue: The segment is still in trials only, with no sales and no material impact yet.

Dedhia: "Thanks, at least you open up that subject again. Yes, let's see now if the market, it looks like the market has again come back and we'll try to figure it out in next coming months and then we will announce very soon."

Guidance & Commitments

Key Metrics